Moderna (MRNA) recently announced that the U.S. government has terminated the previously-awarded contract for the late-stage development of an mRNA-based bird flu vaccine, as well as the right to purchase this vaccine.The Biden administration had awarded two contracts to Moderna over the past year. This includes 590millioninfundingearlierthisyeartoadvancevaccinedevelopment,includingtheexpansionofclinicalstudiesforuptofiveadditionalpandemicinfluenza subtypes.Anothercontractworth1 ...